119 related articles for article (PubMed ID: 20641061)
1. Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions.
Fang ZZ; Zhang YY; Ge GB; Liang SC; Sun DX; Zhu LL; Dong PP; Cao YF; Yang L
Phytother Res; 2011 Feb; 25(2):256-63. PubMed ID: 20641061
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.
Fang ZZ; Zhang YY; Ge GB; Huo H; Liang SC; Yang L
Br J Clin Pharmacol; 2010 Feb; 69(2):193-9. PubMed ID: 20233183
[TBL] [Abstract][Full Text] [Related]
3. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
[TBL] [Abstract][Full Text] [Related]
4. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
Wang X; Cheung CM; Lee WY; Or PM; Yeung JH
Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257
[TBL] [Abstract][Full Text] [Related]
5. Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside.
Sun DX; Lu JC; Fang ZZ; Zhang YY; Cao YF; Mao YX; Zhu LL; Yin J; Yang L
Phytother Res; 2010 Nov; 24(11):1670-5. PubMed ID: 21031626
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.
Song JH; Sun DX; Chen B; Ji DH; Pu J; Xu J; Tian FD; Guo L
J Biosci; 2011 Dec; 36(5):879-85. PubMed ID: 22116286
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Characterization of Reactive Intermediates of Corynoline.
Mao X; Peng Y; Zheng J
Drug Metab Dispos; 2015 Oct; 43(10):1491-8. PubMed ID: 26261285
[TBL] [Abstract][Full Text] [Related]
8. An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes.
Berry LM; Zhao Z
Drug Metab Lett; 2008 Jan; 2(1):51-9. PubMed ID: 19356071
[TBL] [Abstract][Full Text] [Related]
9. Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
Ji HY; Liu KH; Lee H; Im SR; Shim HJ; Son M; Lee HS
Molecules; 2011 Aug; 16(8):6591-602. PubMed ID: 21826053
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of deoxypodophyllotoxin from Anthriscus sylvestris on human CYP2C9 and CYP3A4.
Lee SK; Kim Y; Jin C; Lee SH; Kang MJ; Jeong TC; Jeong SY; Kim DH; Yoo HH
Planta Med; 2010 May; 76(7):701-4. PubMed ID: 19960413
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition.
Taesotikul T; Dumrongsakulchai W; Wattanachai N; Navinpipat V; Somanabandhu A; Tassaneeyakul W; Tassaneeyakul W
Drug Metab Pharmacokinet; 2011; 26(2):154-61. PubMed ID: 21178301
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
15. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.
Korhonen T; Turpeinen M; Tolonen A; Laine K; Pelkonen O
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):56-66. PubMed ID: 18356043
[TBL] [Abstract][Full Text] [Related]
16. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
17. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.
Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G
Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
Jaakkola T; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):44-51. PubMed ID: 16867170
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
Desta Z; Soukhova NV; Flockhart DA
Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
